Assessment of right ventricular responses to therapy in pulmonary hypertension

Drug Discovery Today

Volumn 19, Issue 8, 2014, Pages 1246-1250

  Spruijt, Onno A ^a   Bogaard, Harm Jan ^a   Vonk Noordegraaf, Anton ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT; ANTIHYPERTENSIVE AGENT;

CARDIAC IMAGING; CAUSE OF DEATH; CLINICAL ASSESSMENT; COMPARATIVE STUDY; EXERCISE; HEART AFTERLOAD; HEART EJECTION FRACTION; HEART PERFORMANCE; HEART RIGHT VENTRICLE; HEART VENTRICLE PRESSURE; HUMAN; LUNG VASCULAR RESISTANCE; NUCLEAR MAGNETIC RESONANCE; PATIENT MONITORING; PULMONARY HYPERTENSION; REVIEW; DRUG EFFECTS; HEART RIGHT VENTRICLE FUNCTION; HYPERTENSION, PULMONARY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR RESISTANCE;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, RIGHT;

EID: 84906310121     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.03.008     Document Type: Review

References (52)

1. A. Vonk-Noordegraaf, and N. Galie The role of the right ventricle in pulmonary arterial hypertension Eur. Respir. Rev. 20 2011 243 253
2. N. Galie et al. Guidelines for the diagnosis and treatment of pulmonary hypertension Eur. Respir. J. 34 2009 1219 1263
3. A. Vonk-Noordegraaf, and R. Souza Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension? Am. J. Cardiol. 110 Suppl. 2012 25 31
4. M.L. Handoko et al. Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart Eur. Respir. Rev. 19 2010 72 82
5. H.J. Bogaard et al. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats Am. J. Respir. Crit. Care Med. 182 2010 652 660
6. F.S. de Man et al. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension Circ. Heart Fail. 5 2012 97 105
7. M.C. van de Veerdonk et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy J. Am. Coll. Cardiol. 58 2011 2511 2519
8. J. Nagendran et al. Endothelin axis is upregulated in human and rat right ventricular hypertrophy Circ. Res. 112 2013 347 354
9. J. Nagendran et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility Circulation 116 2007 238 248
10. M.E. van Albada et al. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension Eur. J. Pharmacol. 549 2006 107 116
11. S.A. van Wolferen et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension Eur. Heart J. 28 2007 1250 1257
12. K.M. Chin et al. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension Am. J. Cardiol. 101 2008 1669 1672
13. R.J. Barst et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N. Engl. J. Med. 334 1996 296 301
14. R.J. Roeleveld et al. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension Chest 125 2004 572 579
15. G. Kopec et al. Changes in exercise capacity and cardiac performance in a series of patients with Eisenmenger's syndrome transitioned from selective to dual endothelin receptor antagonist Heart Lung Circ. 21 2012 671 678
16. S.A. van Wolferen et al. Clinically significant change in stroke volume in pulmonary hypertension Chest 139 2011 1003 1009
17. O. Sitbon et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension Am. J. Respir. Crit. Care Med. 170 2004 1212 1217
18. N. Galie et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension J. Am. Coll. Cardiol. 41 2003 1380 1386
19. S.E. Blalock et al. Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension J. Card. Fail. 16 2010 121 127
20. M.R. Wilkins et al. Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study Am. J. Respir. Crit. Care Med. 171 2005 1292 1297
21. S.A. van Wolferen et al. Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension Heart 92 2006 1860 1861
22. Y.J. Shimada et al. Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study J. Am. Soc. Echocardiogr. 23 2010 943 953
23. E. Ostenfeld et al. Manual correction of semi-automatic three-dimensional echocardiography is needed for right ventricular assessment in adults; validation with cardiac magnetic resonance Cardiovasc Ultrasound 10 2012 1
24. H.B. van der Zwaan et al. Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging Eur. J. Echocardiogr. 12 2011 656 664
25. J. Grapsa et al. Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging Eur. J. Echocardiogr. 11 2010 64 73
26. H.J. Nesser et al. Quantitation of right ventricular volumes and ejection fraction by three-dimensional echocardiography in patients: comparison with magnetic resonance imaging and radionuclide ventriculography Echocardiography 23 2006 666 680
27. P.S. Niemann et al. Anatomically oriented right ventricular volume measurements with dynamic three-dimensional echocardiography validated by 3-Tesla magnetic resonance imaging J. Am. Coll. Cardiol. 50 2007 1668 1676
28. T. Sato et al. Validation study on the accuracy of echocardiographic measurements of right ventricular systolic function in pulmonary hypertension J. Am. Soc. Echocardiogr. 25 2012 280 286
29. R. Nijveldt et al. Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance study Eur. Radiol. 18 2008 2399 2405
30. P.R. Forfia et al. Tricuspid annular displacement predicts survival in pulmonary hypertension Am. J. Respir. Crit. Care Med. 174 2006 1034 1041
31. S.B. Brown et al. Longitudinal shortening accounts for the majority of right ventricular contraction and improves after pulmonary vasodilator therapy in normal subjects and patients with pulmonary arterial hypertension Chest 140 2011 27 33
32. G.J. Mauritz et al. Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension Chest 141 2012 935 943
33. J.T. Marcus et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling J. Am. Coll. Cardiol. 51 2008 750 757
34. M.J. Ruiz et al. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience J. Heart Lung Transplant. 25 2006 1353 1357
35. E.D. Michelakis et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension Circulation 108 2003 2066 2069
36. K.L. Dyer et al. Use of myocardial performance index in pediatric patients with idiopathic pulmonary arterial hypertension J. Am. Soc. Echocardiogr. 19 2006 21 27
37. M.G. Kaya et al. Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome J. Card. Fail. 18 2012 379 384
38. I. Sebbag et al. Effect of chronic infusion of epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary pulmonary hypertension Am. J. Cardiol. 88 2001 1060 1063
39. S. Giusca et al. Right ventricular function predicts clinical response to specific vasodilator therapy in patients with pulmonary hypertension Echocardiography 30 2013 17 26
40. M.L. Haeck et al. Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension Circ. Cardiovasc. Imaging 5 2012 628 636
41. Y. Li et al. Right ventricular regional and global systolic function is diminished in patients with pulmonary arterial hypertension: a 2-dimensional ultrasound speckle tracking echocardiography study Int. J. Cardiovasc. Imaging 29 2013 545 551
42. E.L. Hardegree et al. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension Am. J. Cardiol. 111 2013 143 148
43. G.J. Mauritz et al. Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress J. Cardiovasc. Magn. Reson. 14 2012 5
44. N. Westerhof Snapshots of Hemodynamics: An Aid for Clinical Research and Graduate Education 2nd edn 2010 Springer
45. S. Brimioulle et al. Single-beat estimation of right ventricular end-systolic pressure-volume relationship Am. J. Physiol. 284 2003 H1625 H1630
46. D. Chemla et al. Matching dicrotic notch and mean pulmonary artery pressures: implications for effective arterial elastance Am. J. Physiol. 271 1996 H1287 H1295
47. A. Pagnamenta et al. Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure J. Appl. Physiol. 109 2010 1080 1085
48. A. Ghuysen et al. Alteration of right ventricular-pulmonary vascular coupling in a porcine model of progressive pressure overloading Shock 29 2008 197 204
49. M.A. Borgdorff et al. Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle Eur. J. Heart Fail. 14 2012 1067 1074
50. S. Holverda et al. Impaired stroke volume response to exercise in pulmonary arterial hypertension J. Am. Coll. Cardiol. 47 2006 1732 1733
51. A. La Gerche et al. Cardiac MRI: a new gold standard for ventricular volume quantification during high-intensity exercise Circ. Cardiovasc. Imaging 6 2012 329 338
52. B.A. Maron et al. The invasive cardiopulmonary exercise test Circulation 127 2013 1157 1164